Jeff E. Knight - 26 Jun 2024 Form 4 Insider Report for Crinetics Pharmaceuticals, Inc. (CRNX)

Signature
Marc Wilson, as attorney-in-fact
Issuer symbol
CRNX
Transactions as of
26 Jun 2024
Net transactions value
-$42,427
Form type
4
Filing time
28 Jun 2024, 17:31:49 UTC
Previous filing
26 Mar 2024
Next filing
17 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRNX Common Stock Sale $42,427 -956 -1.8% $44.38 52,580 26 Jun 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 Includes 956 shares acquired under the Issuer's Employee Stock Purchase Plan.